Echiquier Health Impact For All A
The sub-fund seeks long-term performance net of management fees through exposure to international equity markets and through companies whose activities provide solutions to the challenges of access to healthcare and which are distinguished by the quality of their governance and their environmental and social policies.
Class A - FR0013441714 - NAV : 117,70€
As of 18/04/2024
Fund news
Transparency, a priority in listed impact investing
Fund Managers
CSIO
Fund manager
A graduate of ESCP Europe, Christine began her career in 1989 with Ernst & Young. In 1991, she joined Oddo & Cie as a European equity analyst, before taking on the same role at Crédit Lyonnais Asset Management. She continued her career as an equity manager, notably of a global healthcare fund, at Natixis AM in 2000, before becoming equity manager and head of responsible European equity and impact investing at Mirova in 2012. In 2014, she joined LBPAM as an equity manager, then Tocqueville Finance in 2020. She then became deputy head of equity management. Since 2024, the year Tocqueville Finance and LFDE merged, she has been CSIO and Head of Social and Health team and co-Head of Growth team of LFDE
Fund manager
A graduate of Paris-Dauphine University (Magistère Banque Finance Assurance), and Bocconi University (Master’s), Louis began his professional career in 2014 at BlackRock as an equity fund analyst. He then joined La Financière de l'Echiquier in 2018 as a blend equity analyst. He subsequently became manager of Echiquier Patrimoine in January 2021, Echiquier Health Impact for all in May 2022 and Echiquier Agressor in January 2023. Since 2024, when Tocqueville Finance and LFDE merged, he has been part of the Social & Health team, the Multi-asset team and the Blend team of LFDE.
Performance
Price dataCalendar performance (%)
Past performance is not an indication of future performance. Returns indicated are after management fees but before taxes paid by the investor.
Calendar performance (%)
| 2024 | |
| Echiquier Health Impact For All A | +5,37 |
| Benchmark | +4,71 |
| 2023 | |
| Echiquier Health Impact For All A | +7,83 |
| Benchmark | +5,72 |
| 2022 | |
| Echiquier Health Impact For All A | -25,51 |
| Benchmark | -2,71 |
| 2021 | |
| Echiquier Health Impact For All A | +14,97 |
| Benchmark | +26,50 |
| 2020 | |
| Echiquier Health Impact For All A | +15,39 |
| Benchmark | +0,16 |
Cumulative performance (%)
| 3 months | |
| Echiquier Health Impact For All A | +4,48 |
| Benchmark | +2,02 |
| 2024 | |
| Echiquier Health Impact For All A | +5,37 |
| Benchmark | +4,71 |
| 1 year | |
| Echiquier Health Impact For All A | +7,88 |
| Benchmark | +4,21 |
| 3 years | |
| Echiquier Health Impact For All A | -8,28 |
| Benchmark | +29,47 |
| 5 years | |
| Echiquier Health Impact For All A | - |
| Benchmark | - |
| 10 years | |
| Echiquier Health Impact For All A | - |
| Benchmark | - |
| Inception | |
| Echiquier Health Impact For All A | +17,70 |
| Benchmark | +49,35 |
Annualised performance (%)
| 1 year | |
| Echiquier Health Impact For All A | +7,86 |
| Benchmark | +4,19 |
| 3 years | |
| Echiquier Health Impact For All A | -2,84 |
| Benchmark | +8,98 |
| 5 years | |
| Echiquier Health Impact For All A | - |
| Benchmark | - |
| 10 years | |
| Echiquier Health Impact For All A | - |
| Benchmark | - |
| Inception | |
| Echiquier Health Impact For All A | +3,62 |
| Benchmark | +9,15 |
Risk indicators (%)
| 1 year | |
| Fund volatility | 12,97 |
| Index volatility | 11,91 |
| Sharpe ratio | 0,57 |
| Information ratio | 0,48 |
| Beta | 0,80 |
| Tracking Error | 9,12 |
| 3 years | |
| Fund volatility | 16,64 |
| Index volatility | 13,06 |
| Sharpe ratio | -0,12 |
| Information ratio | -0,96 |
| Beta | 0,91 |
| Tracking Error | 11,71 |
| 5 years | |
| Fund volatility | - |
| Index volatility | - |
| Sharpe ratio | - |
| Information ratio | - |
| Beta | - |
| Tracking Error | - |
Characteristics
| General characteristics of the fund | |
| Fund Inception | 19/09/2019 |
| Investment management company | La Financière de l'Echiquier |
| Legal form | Sicav (subfund) |
| Classification | International equity |
| Reference indicator | 66.60% MSCI EUROPE HEALTHCARE NR, 33.40% MSCI WORLD HEALTHCARE NR USD (en EUR) |
| Investment horizon | 5 years |
| Periodicity and Listing currency | Daily (EUR) |
| Custodian | BNP Paribas SA |
| Fund Administrator | Société Générale |
| SFDR classification | Article 9 |
| Share class characteristics | |
| Fund Inception | 19/09/2019 |
| ISIN Code | FR0013441714 |
| SRI PRIIPS | 4/7 |
| Minimum subscription amount | Null |
| Investor profile | All investors |
| Tax included Including tax | 1,80% |
| Subscription fee max. tax incl. not retained by the fund | 3,00% |
| Redemption fee max. tax incl. not retained by the fund | 0,00% |
| Management fees and other
administrative and operating expenses (based on the fund's last fiscal year) |
1,82% |
| Transaction costs (based on the average of the fund's last 3 fiscal years) |
0,11% |
Legal information
The information provided above is not contractual and does not constitute investment advice. Past performance is not a reliable indicator of future performance. Management fees are included in performances. The value of the investment may change in line with market fluctuations and investors may lose some or all of their initial investment, as the investment funds carry no capital guarantee. Access to the products and services presented herein may be subject to restrictions for certain people or countries. Taxation depends on each investor’s personal situation. The risks, charges and recommended investment period of the investment funds presented are described in the KIIDs (key investment information documents) and prospectuses available on this website. The KIID must be provided to potential investors prior to subscription.